Free Trial
OTCMKTS:ANSLF

Ansell (ANSLF) Stock Price, News & Analysis

Ansell logo
$23.39 0.00 (0.00%)
As of 02/21/2025

About Ansell Stock (OTCMKTS:ANSLF)

Key Stats

Today's Range
$23.39
$23.39
50-Day Range
$20.80
$23.42
52-Week Range
$15.05
$23.42
Volume
N/A
Average Volume
700 shs
Market Capitalization
N/A
P/E Ratio
75.72
Dividend Yield
1.72%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Ansell Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

ANSLF MarketRank™: 

Ansell scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Ansell.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ansell is 75.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ansell is 75.72, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.79.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Ansell has a short interest ratio ("days to cover") of 68.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Ansell has recently increased by 17.82%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Ansell pays a meaningful dividend of 2.13%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Ansell does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Ansell is 130.40%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Ansell's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Ansell has a short interest ratio ("days to cover") of 68.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Ansell has recently increased by 17.82%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Ansell has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Ansell this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for ANSLF on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ansell insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 38.97% of the stock of Ansell is held by institutions.

  • Read more about Ansell's insider trading history.
Receive ANSLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ansell and its competitors with MarketBeat's FREE daily newsletter.

ANSLF Stock News Headlines

Short Interest in Ansell Limited (OTCMKTS:ANSLF) Increases By 17.8%
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of companies partnering with Nvidia on its latest AI Superproject … Companies we refer to as Nvidia's "Silent Partners" … And they could benefit greatly as well on Feb. 26.
Ansell Limited (ANSLF) Q2 2025 Earnings Call Transcript
RBC Capital Sticks to Its Buy Rating for Ansell (ANSLF)
Ansell (ANSLF) Gets a Hold from UBS
See More Headlines

ANSLF Stock Analysis - Frequently Asked Questions

Ansell's stock was trading at $23.42 on January 1st, 2025. Since then, ANSLF stock has decreased by 0.1% and is now trading at $23.39.
View the best growth stocks for 2025 here
.

Shares of ANSLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Rubber And Plastic Products
Current Symbol
OTCMKTS:ANSLF
CIK
N/A
Fax
N/A
Employees
14,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:ANSLF) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners